Table 5. Comparison of treatment outcomes for hospitalized TB patients in the 309 Hospital stratified by treatment period (patients being treated before and after 2001).

	Treatment success	Poor treatment outcomes	OR (95%CI)	P
Before 2001
Patients with non-MDR -TB
New	27 (71.1)	11 (28.9)	1
Retreatment	117 (84.8)	21 (15.2)	0.44 (0.19,1.02)	0.052
Patients with MDR-TB excluding XDR-TB
New	6 (37.5)	10 (62.5)	1
Retreatment	30 (30.0)	70 (70.0)	1.40 (0.47, 4.20)	0.547
Patients with XDR-TB
New	1 (33.3)	2 (66.7)	1
Retreatment	1 (7.7)	12 (92.3)	6.00 (0.26,140.05)	0.226
After 2001
Patients with non-MDR -TB
New	1088 (92.8)	85 (7.2)	1
Retreatment	1218 (90.6)	127 (9.4)	1.34 (1.00,1.78)	0.048
Patients with MDR-TB excluding XDR-TB
New	89 (59.3)	61 (40.7)	1
Retreatment	157 (59.9)	105 (40.1)	0.98 (0.65, 1.47)	0.906
Patients with XDR-TB
New	4 (33.3)	8 (66.7)	1
Retreatment	8 (40.0)	12 (60.0)	0.75 (0.17,3.35)	0.706
Total
Before 2001
New	34 (59.6)	23 (40.4)	1
Retreatment	148 (59.0)	103 (41.0)	1.03 (0.57, 1.85)	0.924
After 2001
New	1181(88.5)	154 (11.5)	1
Retreatment	1383 (85.0)	244(15.0)	1.35 (1.09, 1.68)	0.006

OR = odds ratio.

CI = confidence interval.

TB = tuberculosis;

MDR = multidrug-resistant;

XDR = extensively drug-resistant.